Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors in Healthy Young and Older Adults

NCT06882096 is registered in ClinicalTrials.gov with Metro International Biotech, LLC as lead sponsor.

NCT NCT06882096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06882096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tracing the Metabolic Flux of Orally Administered NAD+ Precursors in Healthy Young and Older Adults
Lead sponsor
Metro International Biotech, LLC
Phase
Phase 1
Overall status
Recruiting
Start date
April 28, 2025
Completion date
June 30, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults